Samalin Investment Counsel »

Biosante Pharmaceuticals shares owned by Samalin Investment Counsel

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Samalin Investment Counsel from 13F filings

Historical chart of Samalin Investment Counsel investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Samalin Investment Counsel consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Samalin Investment Counsel

Quarter filed Position value Share count Share price at filing
2026-03-31 $605k 7.9k 76.90

More positions owned by Samalin Investment Counsel

Apple (AAPL)
Vaneck Merk Gold Etf Gold Shs (OUNZ)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Core Div Grwth (DGRO)
Ishares Tr Rus Tp200 Gr Etf (IWY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Ishares Tr Msci Eafe Min Vl (EFAV)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Rus Mid Cap Etf (IWR)
Bank of America Corporation (BAC)
Alps Etf Tr Alerian Mlp (AMLP)
Dimensional Etf Trust Us Core Equity 2 (DFAC)

View all positions for Samalin Investment Counsel

Top funds holding Biosante Pharmaceuticals

BlackRock
Vanguard Group
Vanguard Capital Management
Soleus Capital Management
State Street Corporation
Tang Capital Management
Deep Track Capital
Millennium Management
Dimensional Fund Advisors
UBS Group
Geode Capital Management
Arrowstreet Capital, Limited Partnership
Nuveen
Vanguard Portfolio Management
Ranger Investment Management

View all funds holding Biosante Pharmaceuticals